Faith-Based Investor Group Calls for Transparency in Drug Pricing

A group of 300 institutional investors, including many with ties to religious organizations, is waging a new campaign to press drugmakers to justify their price increases.

from WSJ.com: US Business http://ift.tt/2f8SliN
via IFTTT